Contact Us Today!

617-523-7900

or Use Our Simple Online Form to Give Us Feedback

We welcome your comments and feedback. Please include contact information if you'd like a response.

Did you find this page helpful?





If you would like a response, please include your contact information.

 

Title Validation of a candidate biomarker for diabetic retinopathy
MEEI Protocol ID
12-089H
National Clinical Trial (NCT) Number
N/A
Condition Diabetic Retinopathy
Sponsor ONESIGHT RESEARCH FOUNDATION
Principal Investigator
Mara Lorenzi, M.D.
Study Design
Observational study
Study Objective Determine whether the response of the retinal blood vessels to a change in blood pressure provides information about the development of diabetic retinopathy.
Who is Eligible Subjects with type 1 diabetes: males and female 18-50 years of age with minimal to mild degree of diabetic retinopathy of recent onset.  Control subjects: males and females 18-50 years of age with normal blood glucose levels and no history of diabetes.
Subject Enrollment We are currently enrolling individuals with Type 1 Diabetes.  Potential participants will be screened to determine eligibility.
Study Procedures
Measurements of blood pressure and blood glucose (with glucometer); blood drawing for HbA1c measurement; visual acuity exam; intraocular pressure measurement; pupil dilation, retinal photographs; non-invasive measurements of retinal vessels with laser Doppler flowmeter.
For More Information Francesco Tecilazich, M.D.
T: 617-697-7263
francesco_tecilazich@meei.harvard.edu

 

Click here to return to the Ophthalmology Clinical Research page.